These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10221351)

  • 41. Dissociation between the antiatherosclerotic effect of trandolapril and suppression of serum and aortic angiotensin-converting enzyme activity in the Watanabe heritable hyperlipidemic rabbit.
    Chobanian AV; Hope S; Brecher P
    Hypertension; 1995 Jun; 25(6):1306-10. PubMed ID: 7768578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eplerenone inhibits atherosclerosis in nonhuman primates.
    Takai S; Jin D; Muramatsu M; Kirimura K; Sakonjo H; Miyazaki M
    Hypertension; 2005 Nov; 46(5):1135-9. PubMed ID: 16203870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure.
    Kinugawa T; Osaki S; Kato M; Ogino K; Shimoyama M; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
    Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1060-5. PubMed ID: 12390293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
    Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia.
    Wojakowski W; Gminski J; Siemianowicz K; Goss M; Machalski M
    Int J Mol Med; 2000 Nov; 6(5):591-4. PubMed ID: 11029530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal effects of alacepril in essential hypertension.
    Tomita K; Nonoguchi H; Terada Y; Marumo F
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):520-4. PubMed ID: 1280705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs.
    Jacobsson LS; Persson K; Aberg G; Andersson RG; Karlberg BE; Olsson AG
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):670-7. PubMed ID: 7528851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension.
    Mizuno K; Hashimoto S; Kunii N; Tani M; Niimura S; Yabe R; Watari H; Fukuchi S
    Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):175-87. PubMed ID: 2997886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of captopril on atherosclerosis in cynomolgus monkeys.
    Aberg G; Ferrer P
    J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S65-72. PubMed ID: 1694934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antihypertensive mechanism of alacepril: effect on norepinephrine-induced vasoconstrictive response in vitro and in vivo.
    Takeyama K; Minato H; Ikeno A; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):74-7. PubMed ID: 3513780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.
    Hayek T; Attias J; Smith J; Breslow JL; Keidar S
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):540-4. PubMed ID: 9554802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The regressive effect of an angiotensin II receptor blocker on formed fatty streaks in monkeys fed a high-cholesterol diet.
    Takai S; Jin D; Sakaguchi M; Muramatsu M; Miyazaki M
    J Hypertens; 2005 Oct; 23(10):1879-86. PubMed ID: 16148612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of alacepril on 24-hour blood pressure in elderly hypertensive patients.
    Kohara K; Hara-Nakamura N; Takada Y; Iwata T; Ochi T; Kukita H; Muneta S; Hiwada K
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):380-3. PubMed ID: 8880286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
    Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
    J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.
    Mitani H; Bandoh T; Ishikawa J; Kimura M; Totsuka T; Hayashi S
    Br J Pharmacol; 1996 Nov; 119(6):1269-75. PubMed ID: 8937733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diet-induced atherosclerosis in cynomolgus monkey aorta and regression by the sixth-month observation.
    Yamada T; Yoshikuni Y; Taira M; Yoshida-Suzuka H; Kimura K; Sakurai I; Takenaka O
    Angiology; 1992 Dec; 43(12):1008-19. PubMed ID: 1466482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.
    Luo JD; Zhang WW; Zhang GP; Guan JX; Chen X
    Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):903-8. PubMed ID: 10561812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats.
    Jandeleit-Dahm K; Burrell LM; Johnston CI; Koch KM
    J Hypertens; 1997 Jun; 15(6):643-50. PubMed ID: 9218184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced reduction of atherosclerosis in hamsters treated with pravastatin and captopril: ACE in atheromas provides cellular targets for captopril.
    Kowala MC; Valentine M; Recce R; Beyer S; Goller N; Durham S; Aberg G
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):29-38. PubMed ID: 9676717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.